Showing all 5 results
AMLODIPINE & HYDROCHLOROTHIAZIDE TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour hemodynamic control.
Active Ingredient Strength Primary Clinical Function Amlodipine (as Besylate) USP/BP 5 mg / 10 mg The Vasodilator: Reduces the resistance of blood vessels to lower systemic pressure. Hydrochlorothiazide USP/BP 12.5 mg / 25 mg The Volume Reducer: Excretes excess sodium and water to reduce circulatory load. Excipients Proprietary Matrix Steady-State System: Engineered to ensure consistent plasma concentrations of both drugs to prevent “dips” in BP control. ATENOLOL & INDAPAMIDE TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour hemodynamic control.
Active Ingredient Strength Primary Clinical Function Atenolol USP/BP 50 mg The Heart Rate Regulator: Controls cardiac output and myocardial oxygen demand. Indapamide USP/BP 2.5 mg The Metabolic-Neutral Diuretic: Reduces blood volume and provides direct vascular relaxation. Excipients Proprietary Matrix Steady-State Release System: Engineered to ensure consistent plasma concentrations of both drugs to prevent “dips” in BP control. ATENOLOL & S-AMLODIPINE TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, utilizing high-purity S-Amlodipine Besylate to ensure stability.
Active Ingredient Strength Primary Clinical Function Atenolol USP/BP 25 mg / 50 mg The Heart Rate Regulator: Controls the “Pump” by reducing heart rate and myocardial oxygen demand. S-Amlodipine (as Besylate) USP/BP 2.5 mg / 5 mg The Vessel Relaxant: Pure chiral isomer for maximum vasodilation with minimum side effects (edema). Excipients Proprietary Matrix Chiral-Stability System: Engineered to ensure the S-enantiomer remains stable and does not racemize during the shelf-life. Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the stability of the micronized active ingredient.
Active Ingredient Strength Primary Clinical Function Chlorthalidone USP/BP 6.25 mg / 12.5 mg The Contemporary Starting Dose: Highly preferred for modern “Low-Dose” hypertension therapy to maximize pressure control while minimizing electrolyte loss. Chlorthalidone USP/BP 25 mg The High-Potency Payload: Utilized for resistant hypertension or the management of edema associated with heart failure or hepatic cirrhosis. Excipients Microcrystalline Cellulose / Colloidal Silicon Dioxide / Magnesium Stearate / Pregelatinized Starch Diluent / Glidant / Lubricant / Binder (Engineered specifically utilizing Micronized API Technology to ensure absolute uniformity in the 6.25mg and 12.5mg ultra-low-dose tablets, guaranteeing consistent renal response across every batch). Nebivolol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 2.5 mg / 5 mg Global Hypertension Standard: Base therapeutic unit for the continuous, highly tolerated management of essential hypertension. Nebivolol (as HCl) Ph.Eur./USP 10 mg / 20 mg Advanced Cardiac Standard: High-dose maintenance therapy for refractory hypertension and specialized heart failure protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Polysorbate 80 / Magnesium Stearate Diluent / Superdisintegrant / Wetting Agent / Lubricant (Engineered specifically to ensure rapid, predictable gastric dissolution while protecting the delicate racemic balance of the API) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict, high-compliance chronic cardiology dispensing regimens).
